Showing results (31-40 of 4,996) with videos related to

Sort By:
Pageof 500
American Journal of Clinical Oncology|August 24, 2000
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group StudyD S Miller, J A Blessing, L C Kilgore, et al.
American Journal of Clinical Oncology|August 24, 2000
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic studyD Schrijvers, L Pronk, M Highley, et al.
American Journal of Clinical Oncology|August 24, 2000
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantationT R Chauncey, T A Gooley, M E Lloid, et al.
American Journal of Clinical Oncology|August 24, 2000
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumorsS Ricci, A Antonuzzo, L Galli, et al.
American Journal of Clinical Oncology|August 24, 2000
Epithelial ovarian cancer presenting initially with extraabdominal or intrahepatic metastases: a preliminary report of 25 cases and literature reviewR Y Zang, Z Y Zhang, S M Cai, et al.
American Journal of Clinical Oncology|April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II studyV Ferraresi, M Milella, A Vaccaro, et al.
American Journal of Clinical Oncology|April 25, 2000
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II studyM Ychou, J Y Douillard, P Rougier, et al.
American Journal of Clinical Oncology|April 25, 2000
Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomasS Rege, A A Safa, L Chaiken, et al.
American Journal of Clinical Oncology|June 19, 2001
Are DNA ploidy and epidermal growth factor receptor prognostic factors for untreated ovarian cancer? A prospective studyN Nagai, T Oshita, T Fujii, et al.
American Journal of Clinical Oncology|June 19, 2001
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: II. Its impact on clinical response and subsequent surgeryS Motoyama, S Takeuchi, S Hamana, et al.
Pageof 500